Literature DB >> 12767812

Purification of Her-2 extracellular domain and identification of its cleavage site.

Chao-Xing Yuan1, Amy L Lasut, Richard Wynn, Nicola T Neff, Gregory F Hollis, Michael L Ramaker, Mark J Rupar, Phillip Liu, Ray Meade.   

Abstract

The EGF family of receptors belongs to the tyrosine kinase receptor (TKR) family and plays an important role during embryonic and postnatal development and also in the progression of tumors. Her-2/neu/c-erbB-2, a member of the epidermal growth factor receptor family, can be cleaved into a soluble extra cellular domain (ECD) and a membrane-bound stub fragment. Her-2 ECD from a breast cancer cell line SKBR3 was immunopurified and analyzed with matrix-assisted laser desorption ionization (MALDI) and carboxyl terminal amino acid sequencing. A sequence within the juxtamembrane region (only 11 amino acid residues) PAEQR ASP was identified most likely as a primary site of cleavage, PA EQRASP as a minor site, that generate the ECD. The sites of cleavage are within the signature motif P/GX(5-7)P/G highly conserved in the EGF receptor family.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767812     DOI: 10.1016/s1046-5928(03)00058-5

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  18 in total

1.  Trastuzumab and lapatinib modulation of HER2 tyrosine/threonine phosphorylation and cell signaling.

Authors:  D Kostyal; R S Welt; J Danko; T Shay; C Lanning; K Horton; S Welt
Journal:  Med Oncol       Date:  2011-07-16       Impact factor: 3.064

2.  Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients.

Authors:  Patricia Diana Sørensen; Erik Hugger Jakobsen; Jonna Skov Madsen; Eva Brix Petersen; Rikke Fredslund Andersen; Birthe Østergaard; Ivan Brandslund
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-13       Impact factor: 4.553

3.  A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.

Authors:  Kim Pedersen; Pier-Davide Angelini; Sirle Laos; Alba Bach-Faig; Matthew P Cunningham; Cristina Ferrer-Ramón; Antonio Luque-García; Jesús García-Castillo; Josep Lluis Parra-Palau; Maurizio Scaltriti; Santiago Ramón y Cajal; José Baselga; Joaquín Arribas
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

4.  HER2 carboxyl-terminal fragments regulate cell migration and cortactin phosphorylation.

Authors:  Jesús García-Castillo; Kim Pedersen; Pier-Davide Angelini; Joan Josep Bech-Serra; Núria Colomé; Matthew Paul Cunningham; Josep Lluis Parra-Palau; Francesc Canals; José Baselga; Joaquín Arribas
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

Review 5.  Profiling serum HER-2/NEU in prostate cancer.

Authors:  M Siampanopoulou; G Galaktidou; N Dimasis; A Gotzamani-Psarrakou
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

Review 6.  Proteolytic Cleavage of Receptor Tyrosine Kinases.

Authors:  Hao Huang
Journal:  Biomolecules       Date:  2021-04-29

7.  Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5.

Authors:  T M Ward; E Iorns; X Liu; N Hoe; P Kim; S Singh; S Dean; A-M Jegg; M Gallas; C Rodriguez; M Lippman; R Landgraf; M D Pegram
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

8.  Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells.

Authors:  Xiu-Rong Ren; Junping Wei; Gangjun Lei; Jiangbo Wang; Jiuyi Lu; Wenle Xia; Neil Spector; Larry S Barak; Timothy M Clay; Takuya Osada; Erika Hamilton; Kimberly Blackwell; Amy C Hobeika; Michael A Morse; H Kim Lyerly; Wei Chen
Journal:  Breast Cancer Res       Date:  2012-06-07       Impact factor: 6.466

9.  When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase.

Authors:  Ditte Marie Brix; Knut Kristoffer Bundgaard Clemmensen; Tuula Kallunki
Journal:  Cells       Date:  2014-01-27       Impact factor: 6.600

10.  A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis.

Authors:  Kin-Mei Leung; Sarah Batey; Robert Rowlands; Samine J Isaac; Phil Jones; Victoria Drewett; Joana Carvalho; Miguel Gaspar; Sarah Weller; Melanie Medcalf; Mateusz M Wydro; Robert Pegram; Geert C Mudde; Anton Bauer; Kevin Moulder; Max Woisetschläger; Mihriban Tuna; John S Haurum; Haijun Sun
Journal:  Mol Ther       Date:  2015-08-03       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.